Clinical LED Light Therapy, Pain Relief by dpl Light Therapy

The dpl Clinical is specifically FDA-cleared as an OTC Class II medical device for pain relief—distinct from most RLT devices that are cleared for skin indications. It uses 880 nm infrared + 660 nm red wavelengths in a focused panel designed for localized pain management, not skin aesthetics. Its dual-wavelength approach targets both superficial (red) and deep tissue (infrared) pain pathways simultaneously, and it is FSA/HSA approved.

The dpl Clinical targets pain conditions including arthritis-related discomfort, muscle spasms, and general musculoskeletal pain. Its FDA clearance as an OTC Class II medical device means it has been clinically validated for these specific pain-relief indications. The 880 nm infrared wavelength penetrates deep into joints and muscles, while 660 nm red supports surface-level circulation. It is suitable for all skin types and can be used daily for pain management.

The dpl Clinical is FDA-cleared as an OTC Class II medical device for pain relief (FDA 510(k) cleared), which is a higher regulatory standard than most consumer LED devices. It is also FSA/HSA approved, meaning consumers can use pre-tax flexible spending or health savings account funds to purchase it. This regulatory standing distinguishes it from wellness-class competitors.

The dpl Clinical is specifically designed for pain management: arthritis pain, muscle spasms, stiffness, and acceleration of healing. It is not marketed for skin aesthetics (anti-aging, acne, pigmentation). If skin concerns are the primary goal, a different device with skin-specific wavelengths and clearance should be recommended. For practitioners serving clients with both pain and skin needs, pairing the dpl Clinical with a skin-focused LED device covers both indications.